Effect of statin treatment on aortic valve and coronary artery calcification

Journal of Heart Valve Disease

Volumn 16, Issue 4, 2007, Pages 378-386

  Mohler III, Emile R ^a   Wang, Hao ^a   Medenilla, Elizabeth ^a   Scott, Craig ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6;

ADULT; AGED; AORTA VALVE STENOSIS; ARTICLE; BLOOD; CALCINOSIS; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; AORTIC VALVE STENOSIS; C-REACTIVE PROTEIN; CALCINOSIS; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 35448992909     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Carabello BA. Clinical practice. Aortic stenosis. N Engl J Med 2002;346:677-682
2. Mohler ER, III. Are atherosclerotic processes involved in aortic-valve calcification? Lancet 2000;356:524-525 (Pubitemid 30611852)
3. Mohler ER, III. Mechanisms of aortic valve calcification. Am J Cardiol 2004;94:1396-1402, A6 (Pubitemid 39556209)
4. Mohler ER, Gannon FH, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-1528 (Pubitemid 32226259)
5. Demer LL. Lipid hypothesis of cardiovascular calcification. Circulation 1997;95:297-298 (Pubitemid 27056186)
6. Sarig S, Weiss TA, Katz I, et al. Detection of cholesterol associated with calcium mineral using confocal fluorescence microscopy. Lab Invest 1994;71:782-787 (Pubitemid 24374586)
7. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-β1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994;93:2106-2113
8. Mohler ER, Chawla MK, Chang AW, et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999;8:254-260 (Pubitemid 29274326)
9. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: Histological and immunohistochemical studies. Circulation 1994;90:844-853 (Pubitemid 24242754)
10. Barr DP, Rothbard S, Eder HA. Atherosclerosis and aortic stenosis in hypercholesteremic xanthomatosis. JAMA 1954;156:943-947
11. Rallidis L, Naoumova RP, Thompson GR, Nihoyannopoulos P. Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia. Heart 1998;80:583-590 (Pubitemid 28561693)
12. Keller C, Schmitz H, Theisen K, Zollner N. Regression of valvular aortic stenosis due to homozygous familial hypercholesterolemia following plasmapheresis. Klin Wochenschr 1986;64:338-341 (Pubitemid 16124025)
13. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-1307
14. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360:7-22
15. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004;291:1071-1080 (Pubitemid 38541684)
16. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001;88:693-695 (Pubitemid 32831111)
17. Pohle K, Maffert R, Ropers D, et al. Progression of aortic valve calcification: Association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001;104:1927-1932 (Pubitemid 32983236)
18. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104:2205-2209 (Pubitemid 33043301)
19. Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O'Brien KD. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002;359:1125-1126 (Pubitemid 34270741)
20. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002;40:1723-1730 (Pubitemid 35341948)
21. O'Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002;106:2224-2230 (Pubitemid 35222217)
22. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin- converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004;110:1291-1295 (Pubitemid 39202347)
23. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007;49:554-561 (Pubitemid 46177435)
24. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-2397 (Pubitemid 40958435)
25. Callister TQ, Raggi P, Cooli B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electronbeam computed tomography. N Engl J Med 1998;339:1972-1978 (Pubitemid 29024129)
26. Budoff MJ, Lane KL, Bakhsheshi H, et al. Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol 2000;86:8-11 (Pubitemid 30365135)
27. Achenbach S, Ropers D, Pohle K, et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification: A prospective evaluation. Circulation 2002;106:1077-1082 (Pubitemid 34970847)
28. Wu B, Elmariah S, Kaplan FS, Cheng G, Mohler ER, III. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: Implications for end-stage valvular heart disease. Arterioscler Thromb Vase Biol 2005;25:592-597 (Pubitemid 40315683)
29. Kizer JR, Gefter WB, deLemos AS, Scoll BJ, Wolfe ML, Mohler ER, III. Electron beam computed tomography for the quantification of aortic valvular calcification. J Heart Valve Dis 2001;10:361-366 (Pubitemid 32454759)
30. Budoff MJ, Diamond GA, Raggi P, et al. Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation 2002;105:1791-1796 (Pubitemid 34408888)
31. Mohler ER, III, Medenilla E, Wang H, Scott C. Aortic valve calcium content does not predict aortic valve area. J Heart Valve Dis 2006;15:322-328
32. Oh JK, Taliercio CP, Holmes DR, Jr., et al. Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: Prospective Dopplercatheterization correlation in 100 patients. J Am Coll Cardiol 1988;11:1227-1234
33. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis 1998;7:672-707
34. Bonow RO, Cheitlin MD, Crawford MH, Douglas PS. Task Force 3: Valvular heart disease. J Am Coll Cardiol 2005;45:1334-1340 (Pubitemid 40523164)
35. Sanchez PL, Mazzone A. C-reactive protein in degenerative aortic valve stenosis. Cardiovasc Ultrasound 2006;4:24
36. Galante A, Pietroiusti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078-1082 (Pubitemid 32912714)
37. Skowasch D, Schrempf S, Preusse CJ, et al. Tissue resident C-reactive protein in degenerative aortic valves: Correlation with serum C reactive protein concentrations and modification by statins. Heart 2006;92:495-498
38. Sanchez PL, Santos JL, Kaski JC, et al. Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 2006;97:90-93 (Pubitemid 41828129)
39. Raggi P, Davidson M, Callister TQ, et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 2005;112:563-571 (Pubitemid 41060797)
40. Melina G, Horkaew P, Amrani M, Rubens MB, Yacoub MH, Yang GZ. Three-dimensional in vivo characterization of calcification in native valves and in Freestyle versus homograft aortic valves. J Thorac Cardiovasc Surg 2005;130:41-47 (Pubitemid 40941667)